Harrow (HROW) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 11/29/21
Harrow Health's (HROW) CEO Mark L. Baum on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021Business Wire • 10/25/21
Harrow Health Provides $13.5 Million Senior Secured Loan to Melt PharmaceuticalsBusiness Wire • 09/02/21
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.Business Wire • 08/18/21
Harrow Health, Inc. (HROW) CEO Mark Baum on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
Analysts Estimate Harrow Health (HROW) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/03/21
Is Harrow Health (HROW) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 07/28/21
Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from SinteticaBusiness Wire • 07/27/21
Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021GlobeNewsWire • 07/26/21
NovaBay Pharmaceuticals Partners with Harrow Health's ImprimisRx® to Promote Prescription AvenovaBusiness Wire • 07/19/21
Down 14% in 4 Weeks, Here's Why You Should You Buy the Dip in Harrow (HROW)Zacks Investment Research • 07/16/21